The Glioblastoma Multiforme (GBM) Treatment Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Glioblastoma Multiforme (GBM) Treatment Market?
The Glioblastoma Multiforme (GBM) Treatment Global Market was valued at $2.48 billion in 2024 and is projected to reach $2.74 billion in 2025, growing at a compound annual growth rate (CAGR) of 10.2%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Glioblastoma Multiforme (GBM) Treatment Industry?
The Glioblastoma Multiforme (GBM) Treatment Global Market Report anticipates that by 2029, the market will have grown to $4.1 billion, implying a compound annual growth rate (CAGR) of 10.6%.
Download Your Free Sample of the 2025 Glioblastoma Multiforme (GBM) Treatment Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Glioblastoma Multiforme (GBM) Treatment Market?
The key drivers in the glioblastoma multiforme (gbm) treatment market are:
• Emergence of immunotherapies in the field of GBM treatment
• Advancements in precision medicine for tailored treatment approaches
• Enhanced understanding and utilization of genetic markers in diagnosis and treatment
• Increasing patient advocacy, awareness, and government support for rare diseases like GBM
Global Market Segmentation: Identifying Major Glioblastoma Multiforme (GBM) Treatment Industry Segments
The glioblastoma multiforme (GBM) treatment market covered in this report is segmented –
1) By Treatment: Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Tumor Treating Field (TTF) Therapy, Immunotherapy
2) By Drug Class: Temozolomide, Bevacizumab, Lomustine, Carmustine Wafers, Other Drug Classes
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations
4) By End-Use: Hospitals, Clinics, Ambulatory Surgical Centers
Pre-order the 2025 Glioblastoma Multiforme (GBM) Treatment Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Glioblastoma Multiforme (GBM) Treatment Market?
The key trends in the glioblastoma multiforme (gbm) treatment market are:
• Exploration of combination therapies is a rising trend in the GBM treatment market.
• The integration of artificial intelligence in diagnosis and treatment planning is shaping the future of the market.
• There is an increase in adopting immunotherapeutic approaches towards GBM treatment.
• Advancements in medical tools and equipment is a significant emerging trend.
Who Are the Top Competitors & Leading Players in the Glioblastoma Multiforme (GBM) Treatment Market?
Major companies in the glioblastoma multiforme (gbm) treatment market are:
• Pfizer Inc.
• F. Hoffmann-La Roche AG
• Merck & Co. Inc.
• AbbVie Inc.
• Novartis AG
• AstraZeneca PLC
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• Sun Pharmaceutical Industries Limited
• Jazz Pharmaceuticals Inc.
• Sumitomo Dainippon Pharma Oncology Inc.
• Varian Medical Systems Inc.
• Amneal Pharmaceuticals Inc.
• Elekta AB
• ANI Pharmaceuticals Inc.
• Accord Healthcare Limited
• The Eckert & Ziegler Group
• Loxo Oncology Inc.
• Karyopharm Therapeutics Inc.
• Celon Laboratories Pvt. Ltd.
• EnGeneIC Ltd.
• Zydus Pharmaceuticals Inc.
• Genenta Science S.r.l.
• Cantex Pharmaceuticals Inc.
• Vascular Biogenics Ltd.
• Seelos Therapeutics Inc
• Angiochem Inc.
• Diffusion Pharmaceuticals Inc.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the glioblastoma multiforme (GBM) treatment market share in 2024
